Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.390
-0.090 (-2.01%)
At close: May 19, 2026, 4:00 PM EDT
4.350
-0.040 (-0.91%)
After-hours: May 19, 2026, 7:58 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $53.78 million as of May 19, 2026. Its market cap has increased by 215.87% in one year.
Market Cap
53.78M
Enterprise Value
36.05M
1-Year Change
215.87%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $53.78M, a decrease of -16.34%. That is a compound annual growth rate of -3.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 54.88M | 87.15% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 58.14M |
| Impact BioMedical | 58.04M |
| Filana Therapeutics | 57.49M |
| BeyondSpring | 57.36M |
| Dogwood Therapeutics | 56.78M |
| Instil Bio | 55.14M |
| Lixte Biotechnology Holdings | 54.60M |
| iBio, Inc. | 51.32M |